Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation

Sarah Cooley, Peter Parham, Jeffrey S. Miller

Blood (2018) 131 (10): 1053–1062.

https://doi.org/10.1182/blood-2017-08-752170

Published: 2018

Journal Articles

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Tao Wang, PhD, Steven G.E. Marsh, PhD, Elizabeth Trachtenberg, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Guethlein A. Lisbeth, PhD, Martha Ladner, PhD, Peter Parham, PhD, Jeffrey S. Miller, MD, Sarah A. Cooley, MD MS

Blood (2014) 124 (21): 670.

https://doi.org/10.1182/blood.V124.21.670.670

Published: 2014

Journal Articles

Evolution and Immunogenetics of Natural Killer Cell Receptors in Health and Disease

Peter Parham, PhD

Blood (2014) 124 (21): SCI-25.

https://doi.org/10.1182/blood.V124.21.SCI-25.SCI-25

Published: 2014

Journal Articles

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Zachary B. Davis, PhD, Frank Cichocki, PhD, Martin Felices, PhD, Rose Wangen, Todd E. DeFor, MS, Sarah A. Cooley, MD MS, Yenan T. Bryceson, PhD, Don J. Diamond, PhD, Claudio Brunstein, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Amir Horowitz, Lisbeth A Guethlein, Peter Parham, PhD, Michael R. Verneris, MD, Jeffrey S. Miller, MD

Blood (2014) 124 (21): 181.

https://doi.org/10.1182/blood.V124.21.181.181

Published: 2014

Journal Articles

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

Sarah Cooley, MD, Daniel J. Weisdorf, MD, Lisbeth A Guethlein, John P Klein, PhD, Tao Wang, PhD, Steve G.E. Marsh, Stephen Spellman, MBS, Michael D Haagenson, MS, Koy Saeturn, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller, MD

Blood (2013) 122 (21): 549.

https://doi.org/10.1182/blood.V122.21.549.549

Published: 2013

Journal Articles

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

Sarah Cooley, Daniel J. Weisdorf, Lisbeth A. Guethlein, John P. Klein, Tao Wang, Chap T. Le, Steven G. E. Marsh, Daniel Geraghty, Stephen Spellman, Michael D. Haagenson, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S. Miller

Blood (2010) 116 (14): 2411–2419.

https://doi.org/10.1182/blood-2010-05-283051

Published: 2010

Journal Articles

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

Sarah Cooley, Lisbeth Guethlein, PhD, Elizabeth Trachtenberg, PhD, Martha Ladner, Xianghua Luo, Chap T Le, Tao Wang, PhD, John P. Klein, PhD, Steven G.E. Marsh, PhD, Stephen Spellman, Michael D Haagenson, MS, Daniel J. Weisdorf, MD, Peter Parham, Jeffrey S. Miller

Blood (2009) 114 (22): 665.

https://doi.org/10.1182/blood.V114.22.665.665

Published: 2009

Journal Articles

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, Daniel J. Weisdorf

Blood (2009) 113 (3): 726–732.

https://doi.org/10.1182/blood-2008-07-171926

Published: 2009

Includes: Supplemental data

Journal Articles

MHC class I–specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response

Makoto Yawata, Nobuyo Yawata, Monia Draghi, Fotini Partheniou, Ann-Margaret Little, Peter Parham

Blood (2008) 112 (6): 2369–2380.

https://doi.org/10.1182/blood-2008-03-143727

Published: 2008

Includes: Supplemental data

Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD

Blood (2007) 110 (11): 43.

https://doi.org/10.1182/blood.V110.11.43.43

Published: 2007

Journal Articles

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

Sarah Cooley, Feng Xiao, Michelle Pitt, Michelle Gleason, Valarie McCullar, Tracy L. Bergemann, Karina L. McQueen, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller

Blood (2007) 110 (2): 578–586.

https://doi.org/10.1182/blood-2006-07-036228

Published: 2007

Includes: Supplemental data

Journal Articles

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

Jeffery S. Miller, Sarah Cooley, Peter Parham, Sherif S. Farag, Michael R. Verneris, Karina L. McQueen, Lisbeth A. Guethlein, Elizabeth A. Trachtenberg, Michael Haagenson, Mary M. Horowitz, John P. Klein, Daniel J. Weisdorf

Blood (2007) 109 (11): 5058–5061.

https://doi.org/10.1182/blood-2007-01-065383

Published: 2007

Journal Articles

A Subpopulation of Human NK Cells Lacking Inhibitory Receptors for Self MHC Is Developmentally Immature Rather Than Autoreactive.

Sarah Cooley, MD, Feng Xiao, PhD, Michelle Pitt, Michelle Gleason, Valarie McCullar, Tracy Bergemann, Karina McQueen, Lisbeth Guethlein, Peter Parham, PhD, Jeffrey S. Miller, MD

Blood (2006) 108 (11): 918.

https://doi.org/10.1182/blood.V108.11.918.918

Published: 2006

Journal Articles

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Jeffrey S. Miller, MD, Sarah Cooley, MD, Peter Parham, PhD, Michael R. Verneris, MD, Karina McQueen, Libby Guethlein, Sherif Farag, MD, Michael Haagenson, Mary Horowitz, MD, John Klein, PhD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 171.

https://doi.org/10.1182/blood.V108.11.171.171

Published: 2006

Journal Articles

Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I

Monia Draghi, Nobuyo Yawata, Michael Gleimer, Makoto Yawata, Nicholas M. Valiante, Peter Parham

Blood (2005) 105 (5): 2028–2035.

https://doi.org/10.1182/blood-2004-08-3174

Published: 2005

Journal Articles

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

Antonella Mancusi, MSc, Loredana Ruggeri, MD PhD, Karina McQueen, PhD, Katia Perruccio, MD, Franco Aversa, MD, Massimo F. Martelli, MD, Peter Parham, MD PhD, Andrea Velardi, MD

Blood (2004) 104 (11): 2219.

https://doi.org/10.1182/blood.V104.11.2219.2219

Published: 2004

Journal Articles

Reconstitution of NK cell receptor repertoire following HLA -matched hematopoietic cell transplantation

Heather G. Shilling, Karina L. McQueen, Nathalie W. Cheng, Judith A. Shizuru, Robert S. Negrin, Peter Parham

Blood (2003) 101 (9): 3730–3740.

https://doi.org/10.1182/blood-2002-08-2568

Published: 2003

NARROW

Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Evolution and Immunogenetics of Natural Killer Cell Receptors in Health and Disease

Clonal Expansion of Adaptive NK Cells and NKG2C + CD57 + KIR-Expressing T Cells from Sibling, but Not Umbilical Cord Blood, Grafts Is Induced By Recipient Latent CMV and Is Associated with Protection Against CMV Reactivation

Recipient HLA-C1 Enhances The Clinical Advantage Of Killer-Cell Immunoglobulin-Like Receptor B haplotype Donors In Myeloablative Unrelated Transplantation For Acute Myelogenous Leukemia

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

MHC class I–specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

A Subpopulation of Human NK Cells Lacking Inhibitory Receptors for Self MHC Is Developmentally Immature Rather Than Autoreactive.

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

Reconstitution of NK cell receptor repertoire following HLA -matched hematopoietic cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only